GlassScriptPhysician profile
James S Toung
NPI 1609863083
$7,700.59
in general payments reported to CMS, 2019-2025
19 companies · $1,484 in 2025
The $1,484 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,277 · 2020: $423 · 2021: $795 · 2022: $1,085 · 2023: $1,394 · 2024: $1,243 · 2025: $1,484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,120.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,059.92 | 2022-2025 | Inspire |
| Stryker Corporation | $1,656.46 | 2019-2025 | Latera, Xpress Loprofile |
| Intersect Ent, INC. | $644.67 | 2019-2021 | |
| Medtronic, INC. | $582.27 | 2022-2025 | Nuvent, Propel, Sinuva |
| Optinose US, INC. | $528.12 | 2019-2025 | |
| Neurent Medical Limited | $513.89 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Aerin Medical INC. | $478.44 | 2019-2025 | |
| Acclarent, INC | $430.20 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus |
| Regeneron Healthcare Solutions, INC. | $162.52 | 2023-2025 | Dupixent |
| Olympus America INC. | $146.54 | 2019-2024 | |
| Genzyme Corporation | $134.99 | 2022-2023 | |
| Ethicon US, LLC | $127.71 | 2022 | |
| Hikma Pharmaceuticals USA | $66.51 | 2023-2024 | Ryaltris |
| Ars Pharmaceuticals Operations, INC. | $54.95 | 2025 | Neffy |
| Arbor Pharmaceuticals, INC. | $30.05 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $29.15 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Glaxosmithkline, LLC. | $22.92 | 2022 | |
| Lilly USA, LLC | $16.32 | 2025 | Zepbound |
| Karl Storz Endoscopy-America | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Toung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.